Literature DB >> 19485837

Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes?

Robyn L Woods, Andrew M Tonkin, Mark R Nelson, Helena C Britt, Christopher M Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19485837

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetes.

Authors:  Rui Li; Ping Zhang; Lawrence E Barker; Thomas J Hoerger
Journal:  Diabetes Care       Date:  2010-03-23       Impact factor: 17.152

2.  Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.

Authors:  Greg Ong; Timothy M E Davis; Wendy A Davis
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.